'Primary' Microvascular Angina: Clinical Characteristics, Pathogenesis and Management [0.03%]
原发性微血管心绞痛的临床特点、发病机制及处理措施
Gaetano Antonio Lanza,Antonio De Vita,Juan-Carlos Kaski
Gaetano Antonio Lanza
Microvascular angina (MVA), i.e. angina caused by abnormalities of the coronary microcirculation, is increasingly recognised in clinical practice. The pathogenetic mechanisms of MVA are heterogeneous and may involve both structural and func...
Simon Kennon
Simon Kennon
Erratum to: Minimally Invasive Surgical Mitral Valve Repair: State of the Art Review [0.03%]
微创外科二尖瓣修复的现状及展望（论文勘误）
Karel M Van Praet,Christof Stamm,Simon H Sündermann et al.
Karel M Van Praet et al.
[This corrects the article on p. 14 in vol. 13, PMID: 29593831.].
Non-vitamin K Antagonist Oral Anticoagulant After Acute Coronary Syndrome: Is There a Role? [0.03%]
急性冠脉综合征后新型口服抗凝药物的作用？
Paul Guedeney,Birgit Vogel,Roxana Mehran
Paul Guedeney
Despite dual antiplatelet therapy (DAPT) including potent P2Y12 inhibitors, recurrent ischaemic events occur in a significant number of patients after acute coronary syndrome (ACS), warranting new antithrombotic strategies. Combinations of ...
Eunice Nc Onwordi,Amr Gamal,Azfar Zaman
Eunice Nc Onwordi
Anticoagulation in conjunction with antiplatelet therapy is central to the management of acute coronary syndromes (ACS). When used effectively it is associated with a reduction in recurrent ischaemic events including myocardial infarction a...
Alexander G Truesdell,Behnam Tehrani,Ramesh Singh et al.
Alexander G Truesdell et al.
The incidence of cardiogenic shock is rising, patient complexity is increasing and patient survival has plateaued. Mirroring organisational innovations of elite military units, our multidisciplinary medical specialists at the INOVA Heart an...
Transseptal Transcatheter Mitral Valve Replacement for Post-Surgical Mitral Failures [0.03%]
术后二尖瓣病变的穿隔导管二尖瓣置换术
Marvin H Eng,Dee Dee Wang
Marvin H Eng
Post-surgical deterioration of mitral valve repairs or replacements may present a clinical dilemma due to the high-risk nature of repeat surgery. Recent advances in transcatheter techniques and surgery have enabled the implantation of ballo...
Coronary Revascularisation in Transcatheter Aortic Valve Implantation Candidates: Why, Who, When? [0.03%]
主动脉瓣植入术候选患者的冠状动脉再血管化：为何、何人及何时？
Davide Cao,Mauro Chiarito,Paolo Pagnotta et al.
Davide Cao et al.
Coronary artery disease (CAD) and aortic stenosis (AS) frequently coexist. The presence of CAD has been consistently associated with an impaired prognosis in patients undergoing surgical aortic valve replacement during short- and long-term ...
Transcatheter Aortic Valve Implantation in Small Anatomy: Patient Selection and Technical Challenges [0.03%]
解剖结构较小患者的经导管主动脉瓣植入术：患者选择及技术挑战
Makoto Nakashima,Yusuke Watanabe
Makoto Nakashima
Transcatheter aortic valve implantation (TAVI) has become a standard treatment for severe aortic stenosis. Although this technique has reached relative maturity, further optimisation of patient selection and device implantation is essential...